Exchange: NASDAQ
Industry: Biotechnology
Last Trade: 2:31 PM ET 2/9/2012
Last 10 Quotes:
What's This?
Find a Broker »
- li>
- li>
- li>
- li>
- li>
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | -0.45 | -0.22 | -104.55 |
| EPS, GAAP | -0.45 | -0.22 | -104.55 |
| Consensus Estimate | -0.39 | -0.36 | -8.33 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | -2.02 | -1.24 | -62.90 |
| EPS, GAAP | -2.02 | -0.85 | -137.65 |
| Consensus Estimate | -1.72 | NA | NA |
| HGSI | Industry Average | |
| P/E (TTM) | -4.89 | 86.30 |
| P/E (Forward) | NA | -4.30 |
| PEG Ratio | NA | -0.21 |
| Price/Sales | 18.19 | 4.64 |
| Beta | 3.89 | 4.32 |
| 2/8/2012 | Finding companies that have all the right stuff can produce winners. (The Motley Fool) |
| 1/27/2012 | Finding companies that have all the right stuff can produce winners. (The Motley Fool) |
| 1/26/2012 | There's no need to guess which company will perform best. (The Motley Fool) |
| 1/26/2012 | Tracking The Unusual Short Interest Trends (ALU, BAC, DNDN, DMND, FSLR, F, GMCR, HGSI, LNKD, NFLX, RIMM, SIRI) (24/7 Wall St) |
| 1/25/2012 | 5 Big Drugs for 2012 (Barrons.com) |
| 1/25/2012 | Market-lagging returns could be written in this two-star. (The Motley Fool) |
| 1/20/2012 | Bargains in the Biotech Sector (Barrons.com) |
| 1/19/2012 | ArcelorMittal, Ariad Pharma, and Human Genome zig as Wall Street zags. (The Motley Fool) |
![[sm0212smart]](http://s.wsj.net/public/resources/images/PF-AB863_sm0212_C_20120118122431.jpg)
![[smfineprint]](http://s.wsj.net/public/resources/images/PF-AB821_smfine_C_20120111122044.jpg)
![[sm0212funds]](http://s.wsj.net/public/resources/images/PF-AB839_sm0212_C_20120113140400.jpg)
![[sm0212ten]](http://s.wsj.net/public/resources/images/PF-AB840_sm0212_C_20120117120334.jpg)